Center for Genomics and Healthcare Equality

$927,353P50FY2013HGNIH

University Of Washington, Seattle WA

Investigators

Linked publications & trials

Paper 32342749 Paper 31511188 Paper 30359103 Paper 29962827 Paper 29048417 Paper 28796237 Paper 28556620 Paper 28374161 Paper 28361104 Paper 28346599 Paper 28125087 Paper 27999980 Paper 27939182 Paper 27901429 Paper 27891830 Paper 27734877 Paper 27613778 Paper 27011058 Paper 26855553 Paper 26479558 Paper 26479557 Paper 26147255 Paper 25764215 Paper 25719903 Paper 25419472 Paper 24946153 Paper 24830328 Paper 24772384 Paper 24763995 Paper 24688162 Paper 24626283 Paper 24481117 Paper 24321254 Paper 24134376 Paper 23977642 Paper 23928914 Paper 23907645 Paper 23763673 Paper 23448723 Paper 23253665 Paper 23221293 Paper 22955111 Paper 22899092 Paper 22836698 Paper 22582247 Paper 22516979 Paper 22491085 Paper 22488458 Paper 22453194 Paper 22390411 Paper 22346758 Paper 22323071 Paper 22261761 Paper 22241102 Paper 22241094 Paper 22228056 Paper 22174311 Paper 22152167 Paper 22038764 Paper 21943371 Paper 21934059 Paper 21816897 Paper 21747109 Paper 21736136 Paper 21709145 Paper 21632745 Paper 21487211 Paper 21071927 Paper 20929761 Paper 20831419 Paper 20808229 Paper 20592417 Paper 20407215 Paper 20395690 Paper 20371468 Paper 20364081 Paper 20347647 Paper 20235866 Paper 20157827 Paper 19668081 Paper 19204414 Paper 19170033 Paper 19066388 Paper 18570105 Paper 18496223 Paper 18496219 Paper 18376110 Paper 18200521 Paper 18073583 Paper 18073580 Paper 17925520 Paper 17486108 Paper 17468539 Paper 17119145 Paper 17108808 Paper 17085405 Paper 16829241 Paper 16284369

Abstract

DESCRIPTION (provided by applicant): Genomic research is rapidly expanding our knowledge about the genetic contributors to health and disease. A broad range of health benefits will flow from this research, including tests to predict disease risk and guide drug use, innovative therapies, and improved understanding of the interactions between genetic and environmental contributors to health. How ever, the specific benefits will vary for different diseases and populations, influenced by the nature of the genetic and non-genetic contributors, and the availability and safety of therapeutic options. T he likelihood of benefit for a particular individual or group will also be influenced by social, political and economic factors such as access to health care, meaning attached to genetic risk information, and cost and acceptability of specific interventions. In particular, medically underserved and marginalized populations may experience greater barriers to receiving benefit from genomic health applications, with the potential for genomics to exacerbate existing health disparities. In this renewal application of the Center for Genomics and Healthcare Equality, we will build on our existing work to develop methods for enhancing the benefits of genomic translation, with particular attention to the use of genomic technology to address population health and health disparities. The specific aims of our center are to: (1) Characterize the range of challenges and opportunities in the translation process from genomic discovery to health benefit with an emphasis on targeting benefits for medically underserved populations; (2) Develop methods to build and evaluate university -community and interdisciplinary partnerships, including deliberative processes and strategies to identify common ground; (3) Develop tools to assist decision-making about the clinical use and reimbursement of genomic health applications; (4) Provide training opportunities to encourage the participation of researchers from underrepresented minorities in the Center's research agenda and other ELSI research; (5) Stimulate collaborative partnerships that result in additional funded research addressing these and related questions.

View original record on NIH RePORTER →